Subscribe to My Feed
Loading ...
Colombia Imposes Take-Back for Expired Medicines
Monday, March 2nd, 2009Two years ago Environment Minister got the attention of industry when he published for public comment two draft decrees imposing extended producer responsibility (EPR) for end-of-life batteries and medicines.
Now, after nearly two years of discussions between the Environment Ministry (MAVDT) and industry groups representing the pharmaceutical sector in Colombia — namely the Colombian Pharmaceutical Industry [...]
A Call for Scaled-Up R&D for Neglected Diseases / Una llamada para más I+D para las enfermedades olvidadas / Uma chamada para aumento de P&D sobre as doenças negligenciadas
Monday, February 23rd, 2009From the Drugs for Neglected Diseases initiative (DNDi):
MSF and DNDi Call for Scale-Up of R&D for Neglected Diseases
Greater Governmental Leadership is needed to Foster Medical Innovation for Millions Suffering from Neglected Diseases
The international medical humanitarian organization Médecins Sans Frontières (MSF) and the Drugs for Neglected Diseases initiative (DNDi) called today for more sustainable funding [...]
DR & Central America Agree on Common Health, Pharma Policies/Programs
Saturday, January 31st, 2009It doesn’t get much attention outside this corner of Latin America and the Caribbean (LAC), but the annual Meeting of the Health Sector of Central America and the Dominican Republic (Reunión del Sector Salud de Centro América y República Dominicana - RESSCAD) is quietly doing important work to change health policy among its seven member [...]
Cuba to Help Argentina Produce Cancer, Antiretroviral Drugs
Thursday, January 29th, 2009Argentina’s Health Minister Graciela Ocaña has just signed an agreement with Cuba where the latter will aid the former in researching and producing antiretroviral medicines (ARVs), cancer drugs, vaccines and other treatments for diseases prevalent in Argentina.
Last year, shortly after assuming her post, Ocaña established the Program for the Public Production of Medicines, Vaccines and [...]
Fiocruz Gets Green Light to Produce AIDS Medicine Under Compulsory License
Wednesday, January 28th, 2009Brazil’s National Sanitary Vigilance Agency (ANVISA) has authorized the Pharmaceutical Technology Institute (”Farmanguinhos“) of the Oswaldo Cruz Foundation (”Fiocruz“) to begin producing the antiretriviral drug Efavirenz. About 80,000 Brazilian HIV-positive patients currently receive the drug through the National Program on Sexually-Transmitted Diseases (STDs) and AIDS.
To refresh memories, Efavirenz is the AIDS drug for which Brazil [...]
Gates Foundation Funds WHO/UNICEF Research on Children’s Medicines
Wednesday, January 21st, 2009From the World Health Organization (WHO):
WHO receives funds for children’s medicines research with UNICEF
US$ 9.7 million grant from Gates Foundation to help crucial research on children’s medicines
WHO has received US$ 9.7 million in grant from the Bill & Melinda Gates Foundation to work with UNICEF to conduct crucial research in children’s medicines, with the aim [...]
MERCOSUR Adopts Guidelines on Promotion, Advertising & Marketing of Pharmaceuticals
Tuesday, December 30th, 2008I’ve said here many times that Latin American and Caribbean (LAC) nations tend to take seriously the recommendations, guidelines and other soft norms of the World Health Organization (WHO) on any issue involving public health and/or the environment, and I’ve tried to provide a few examples where WHO work has translated into national laws and [...]
New Brazilian Rules on Pharmaceutical Marketing
Wednesday, December 24th, 2008Brazil’s Health Minister, José Gomes Temporão, and the head of the National Health Surveillance Agency (Anvisa), Dirceu Raposo, recently announced new rules on pharmaceutical marketing in that country to replace less ambitious ones adopted in 2000. The new rules aim at substantially changing how medicines are promoted in Latin America’s largest pharma market, and may [...]
Brazil Proceeds with Compulsory Licensing of Antiretroviral Drug / Brasil continua com a licença compulsória de medicamento antiretroviral
Monday, October 6th, 2008Temas Observation: All developing nations have had the clear right to resort to compulsory licensing of pharmaceuticals since the adoption of the Doha Declaration by the World Trade Organization (WTO) in 2001. Brazil has long reserved this right under its own laws, although previously it has been hesitant to actually use the power, preferring instead [...]
Los Países Andinos deciden diseñar una política regional sobre acceso universal al medicamento
Sunday, October 5th, 2008Synopsis in English: The Andean Health Organism - Hipólito Unanue Convention (ORAS-CONHU) — the health cooperation agency that brings together the four Andean Community (CAN) member states (Bolivia, Colombia, Ecuador, Peru) with two former CAN members, Chile and Venezuela — has decided to formulate a regional policy guaranteeing universal access to medicines. The policy should [...]
« Previous Entries